What is PotBotics?
PotBotics operates at the intersection of data aggregation and advanced technology, specifically targeting the global medical cannabis industry. The company has developed a sophisticated artificial intelligence platform designed to collect and correlate HIPAA-compliant medical data. This enables healthcare professionals and patients to achieve more personalized cannabis treatments, thereby improving the prediction of therapeutic outcomes. Furthermore, PotBotics is set to launch RYAH, a pioneering dose-measuring vaporizer. This device is expected to yield unique data on user consumption patterns, contribute to cannabinoid research, and provide critical business intelligence. PotBotics' robust intellectual property portfolio for innovative products and services positions it to gather comprehensive insights into the cannabis lifecycle, from cultivation to consumption.
How much funding has PotBotics raised?
PotBotics has raised a total of $2.4M across 1 funding round:
Debt
$2.4M
Debt (2014): $2.4M, investors not publicly disclosed
What's next for PotBotics?
The substantial enterprise-level funding PotBotics has attracted signals a strong market confidence in its innovative approach to medical cannabis data and technology. This capital infusion is likely to accelerate the development and rollout of its AI platform and the RYAH vaporizer. The company is poised to further solidify its position as a leader in providing data-driven solutions for personalized cannabis therapy and research, potentially expanding its market reach and enhancing its data analytics capabilities to drive future growth and innovation in this rapidly evolving sector.
See full PotBotics company page
